CTVA · Corteva, Inc.
$88.78
-1.01% last session
End-of-day data · updated 2026-07-25
Market cap
$60B
Enterprise value
$61B
Trailing P/E
48.2
Forward P/E
21.6
Dividend yield
1.0%
Beta
0.56
Avg volume
4M
Employees
22K
2D change
0.53%
5D change
2.85%
10D change
5.68%
30D change
9.35%
60D change
13.11%
MTD change
6.84%
YTD change
33.76%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CTVA
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-23
Latest call per bank · past 12 months
RBC Capital
Outperform$103
+16.0% vs priceBank of America
Buy$96.00
+8.1% vs priceBarclays
Overweight$91.00
+2.5% vs priceUBS
Neutral$86.00
-3.1% vs priceMorgan Stanley
Overweight$95.00
+7.0% vs priceCitigroup
Neutral$85.00
-4.3% vs priceWells Fargo
Overweight$90.00
+1.4% vs priceJP Morgan
Neutral$77.00
-13.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-23 | Oppenheimer | Maintains | Outperform | $89.00 → $95.00 |
| 2026-07-21 | RBC Capital | Maintains | Outperform | $97.00 → $103 |
| 2026-07-20 | Bank of America | Maintains | Buy | $90.00 → $96.00 |
| 2026-07-14 | Mizuho | Maintains | Outperform | $96.00 → $97.00 |
| 2026-07-02 | Mizuho | Maintains | Outperform | $94.00 → $96.00 |
| 2026-06-11 | Barclays | Maintains | Overweight | $84.00 → $91.00 |
| 2026-06-09 | UBS | Maintains | Neutral | $90.00 → $86.00 |
| 2026-05-28 | Morgan Stanley | Maintains | Overweight | $84.00 → $95.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-27
- RSI (14): RSI is 64 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.0% above the 50-day MA ($81.40).
- Price vs 200-day MA: Trading 18.2% above the 200-day MA ($74.38).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.11) — short-term momentum is improving.
- 52-week range: Price is within 5% of the 52-week high ($88.78).
CTVA Price Chart
Loading chart for CTVA…
Fundamentals
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
More in Agricultural Inputs
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.